Literature DB >> 14742292

A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women.

Denise M Boudreau1, Janet R Daling, Kathleen E Malone, Jacqueline S Gardner, David K Blough, Susan R Heckbert.   

Abstract

A validation study evaluated the accuracy of self-reported use of commonly used medications among older women. Within a case-control study of breast cancer, drug information was ascertained by interview. Pharmacy records from 1990 to 1999 were obtained from a Washington State health maintenance organization (66% of subjects) and retail pharmacies (34% of subjects) on a sample of subjects (212 cases, 191 controls) and used as the "gold standard." Recall accuracy was assessed for 6-month, 2-year, and 8-year time windows. Sensitivity of antihypertensive use was 92% (95% confidence interval (CI): 85, 96) for cases and controls in the 6-month period and slightly lower for the 2-year (90% (95% CI: 82, 94) and 87% (95% CI: 78, 92)) and 8-year (80% (95% CI: 69, 88) and 79% (95% CI: 68, 88)) periods. For statins, sensitivity was 83% (95% CI: 64, 93) for cases and 93% (95% CI: 69, 99) for controls in the 6-month period, 75% (95% CI: 55, 88) and 86% (95% CI: 60, 96) in the 2-year period, and 67% (95% CI: 42, 85) and 75% (95% CI: 41, 93) in the 8-year period. For self-report of antidepressants, sensitivities ranged from 66% (95% CI: 47, 80) in the 6-month period to 44% (95% CI: 30, 60) in the 8-year period. Specificity was high among all drug classes, ranging from 91% to 100%. Recall did not differ by case-control status. Trivial changes in estimates were observed when health maintenance organization records alone were used as the gold standard. Self-reported use of antihypertensives and statins appears to be relatively accurate among older women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742292     DOI: 10.1093/aje/kwh038

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  44 in total

1.  Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.

Authors:  Diana S M Buist; Rod Walker; Erin J Aiello Bowles; Patricia A Carney; Stephen H Taplin; Tracy Onega; Karla Kerlikowske; Walter Clinton; Diana L Miglioretti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-01       Impact factor: 4.254

2.  Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.

Authors:  Simone R B M Eussen; Johanna M Geleijnse; Erik J Giltay; Cathy J M Rompelberg; Olaf H Klungel; Daan Kromhout
Journal:  Eur Heart J       Date:  2012-02-01       Impact factor: 29.983

3.  Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.

Authors:  Kerryn W Reding; David R Doody; Anne McTiernan; Li Hsu; Scott Davis; Janet R Daling; Peggy L Porter; Kathleen E Malone
Journal:  Breast Cancer Res Treat       Date:  2010-09-29       Impact factor: 4.872

4.  Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.

Authors:  Kerryn W Reding; Christopher I Li; Noel S Weiss; Chu Chen; Christopher S Carlson; David Duggan; Kenneth E Thummel; Janet R Daling; Kathleen E Malone
Journal:  Am J Epidemiol       Date:  2009-10-21       Impact factor: 4.897

5.  Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort.

Authors:  Marianne Haapea; Jouko Miettunen; Sari Lindeman; Matti Joukamaa; Hannu Koponen
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

6.  Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study.

Authors:  Lillian R Meacham; Eric J Chow; Kirsten K Ness; Kala Y Kamdar; Yan Chen; Yutaka Yasui; Kevin C Oeffinger; Charles A Sklar; Leslie L Robison; Ann C Mertens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

7.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

8.  Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort.

Authors:  Joan A Largent; Leslie Bernstein; Pamela L Horn-Ross; Sarah F Marshall; Susan Neuhausen; Peggy Reynolds; Giske Ursin; Jason A Zell; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer Causes Control       Date:  2010-06-06       Impact factor: 2.506

9.  Associations between medication use and homocysteine levels in an older population, and potential mediation by vitamin B12 and folate: data from the B-PROOF Study.

Authors:  Annelies C Ham; Anke W Enneman; Suzanne C van Dijk; Sadaf Oliai Araghi; Karin M A Swart; Evelien Sohl; Janneke P van Wijngaarden; Nikita L van der Zwaluw; Elske M Brouwer-Brolsma; Rosalie A M Dhonukshe-Rutten; Natasja M van Schoor; Tischa J M van der Cammen; M Carola Zillikens; Robert de Jonge; Paul Lips; Lisette C P G M de Groot; Joyce B J van Meurs; André G Uitterlinden; Renger F Witkamp; Bruno H C Stricker; Nathalie van der Velde
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

10.  Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.

Authors:  P A Newcomb; A Trentham-Dietz; J M Hampton
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.